Editors
Editors-in-Chief
Paul Aisen, MD, Alzheimer’s Therapeutic Research Institute (ATRI), San Diego, USA)Sandrine Andrieu, MD, PhD, University Paul Sabatier, INSERM CERPOP, Toulouse, France
Serge Gauthier, CM, MD, FRCPC, McGill Center for Studies in Aging, Québec, Canada
Jacques Touchon, MD, PhD, University of Montpellier, Montpellier, France
Sections and Associate Editors
Frédéric Blanc, MD, PhD , HdR, Service de Gérontologie Mobile-Neuro-Psy-Recherche et CM2R, France
Audrey Gabelle. MD, PhD, Cognitive Science Alzheimer, Sciences department Biogen, Biogen Digital Health. Paris and Cambridge, France, UK
Ara Khachaturian, MD, Campaign to Prevent Alzheimer's disease, Rockville, USA (Health Economics and Finance Aspects)
Zaven Khachaturian, PhD, Campaign to Prevent Alzheimer's disease, Rockville, USA, (Health Policy, Regulations)
Miia Kivipelto, PhD, Karolinska Institut, Stockholm, Sweden (Health Promotion)
Rachel Nosheny, PhD, UCSF Weill Institute for Neurosciences, San Francisco, USA (Cognitive and interest assessment)
Okonkwo Ozioma, PhD, University of Wisconsin, Madison, USA (Under represented population)
Michael Rafii, MD, PhD, University of Southern California, San Diego, USA, (Clinical trials)
Robert Rissman, PhD, University of Southern California, San Diego, USA (Biomarkers research)
Marwan Sabbagh, MD, Barrow Neurological Institute, Phoenix, USA (Clinical Trials)
Duygu Tosun, PhD, University of California San Francisco, San Francisco, USA (IRM)
Natalio Vita, PhD, Institut on Aging, University Paul Sabatier, Toulouse, France (Pre-Clinical Study)
Michael Weiner, MD, University of California at San Francisco, San Francisco, USA (Imaging and Biomarkers)
Editorial Board
Rebecca Amariglio, PhD, Brigham and Women’s Hospital, Boston, USA (Epidemiology)
Randall Bateman, MD, Washington University School of Medicine, Saint Louis, USA (Biomarkers)
David Bennett, MD, Rush University Medical Center, Chicago, USA (Epidemiology)
Tobias Bittner, PhD, Genentech/Roche, Basel, Switzerland (Biomarkers)
Kaj Blennow, MD, PhD, University of Gothenburg, Mölndal, Sweden (Biomarker)
Mercé Boada, MD, PhD, Fundacion ACE, Barcelona, Spain (Essai thérapeutique)
Carol Brayne, MD, University of Cambridge, Cambridge, United Kingdom (Epidemiology)
John Breitner, MD, MPH, McGill Center for Studies in Aging, Montreal, Canada (Epidemiology)
Maria Carrillo, PhD, Alzheimer’s Association, Chicago, USA (Essai thérapeutique)
Jesse Cedarbaum, MD, Yale School of Medicine, New Heaven, CT, USA (Phase Pré-clinique)
Piu Chan, MD, PhD, Xuanwu Hospital of Capital Medical University, Beijing, China (Epidemiology)
Felipe A. Court, PhD, Center for Integrative Biology, Universidad Mayor, Chile
Suzanne Craft, PhD, Wake Forest Baptist Health, Winston-Salem, USA (Essai Clinique)
Jeffrey Cummings, MD, Cleveland Clinic Lou Ruvo Center for Brain, Las Vegas, USA (Essai clinique)
Michael Donohue, PhD, University of California, San Diego, USA (Epidemiology)
Rachelle Doody, MD, PhD, Roche, Bâle, Switzerland (Essai thérapeutique)
Lei Feng, PhD, National University of Health System, Singapore (Biomarkers)
Howard Fillit, MD, Alzheimer’s Drug Discovery Foundation, New York, USA (Biomarkers)
Joshua Grill, PhD, University of California, Irvine, USA
Michael Grundman, MD, University of California San Diego, San Diego, USA (Essai thérapeutique)
Deborah Gustafson, MS, PhD, State University of New York, New York, USA (Epidemiology)
Harald Hampel, MD, PhD, Eisai Inc., Nutley, New Jersey USA (Essai thérapeutique)
Tobias Hartmann, MD, Saarland University, Saarland, Germany (Essai thérapeutique)
Timothy Kwok, MD, The Chinese University of Hong Kong, Shalin, Hong Kong (Multidomaine)
Jessica Langbaum, PhD, Banner Alzheimer’s Institute, Phoenix, USA (Essai thérapeutique)
Yunhwan Lee, MD, DrPH, Ajou University School of Medicine, Suwon, Republic of Korea
Yan Li, PhD, Knight Alzheimer Disease Research Center, St. Louis, USA
Jorge Llibre Guerra, MD, Knight Alzheimer Disease Research Center, St. Louis, USA
Frank Longo, MD, PhD, Stanford University School of Medicine, Stanford, USA (Essai thérapeutique)
José Luchsinger, MD, Columbia University, New York, USA (Epidemiology)
Kostas Lyketsos, MD, John Hopkins Medicine, Baltimore, USA (Essai thérapeutique)
Gad Asher Marshall, MD, Harvard Medical School, Boston, USA
Colin Masters, MD, The University of Melbourne, Parkville, Australia (Essai thérapeutique)
Eric McDade, DO, Washington University School of Medicine, Saint Louis, USA
Moon So Young, MD, PhD, Ajou University, Suwon, South Korea (Epidemiology)
Ronald Petersen, MD, PhD, Mayo Clinic, Rochester, USA (Essai thérapeutique)
Yakeel Quiroz, PhD, Harvard Medical School, Boston, USA (Essai thérapeutique)
Rema Raman, PhD, University of Southern California, San Diego, USA (Epidemiology)
Eric Reiman, MD, Banner Alzheimer’s Institute, Phoenix, USA (Biomarkers)
Edo Richard, PhD, University of Amsterdam, Amsterdam, The Netherlands (Multidomaine)
Craig Ritchie, MD, Imperial College of London, London, United Kingdom (Multidomaine)
Paul Rosenberg, MD, John Hopkins University School of Medicine, Baltimore, USA (Essai thérapeutique)
Stephen Salloway, MD, The Warren Alpert Medical School of Brown University, Providence, USA (Essai thérapeutique)
Rachel Schindler, MD, Schindler Consulting, New York, USA (Epidemiology)
Jiong Shi, MD, PhD , Beijing Tiantan Hospital, Beijing, China (Essai thérapeutique)
Eric Siemers, MD, Acumen Pharma, Charlottesville, USA (Phase pré clinique)
Reisa Sperling, MD, Brigham and Women’s Hospital, Boston, USA (Essai thérapeutique)
Marc Suarez, MD, Barcelona Brain Research Center, Barcelona, Spain
Joyce Suhy, PhD, Clario, San Mateo, USA (Imagerie)
Pierre Tariot, MD, Banner Alzheimer’s Institute, Phoenix, USA (Essai thérapeutique)
Ron Thomas, PhD, University of Southern California, San Diego, USA (Epidemiology)
Christopher van Dyck, MD, Yale University School of Medicine, New Haven, USA (Essai thérapeutique)
Bruno Vellas, MD, PhD, IHU Health Age, Toulouse, France (Essai thérapeutique)
Sylvia Villeneuve, PhD, McGill University, Montreal, Canada (Multidomaine)
Peng Wang, MBBS, MMed Int Med, MRCP, MHPE, Institute of Geriatrics and Active Aging, Tan Tock Seng Hospital, Singapore (Epidemiology)
Kristine Yaffe, MD, University of California, San Francisco, USA (Epidemiology)